Obesity task force linked to WHO takes “millions” from drug firmsBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7555.1412-a (Published 15 June 2006) Cite this as: BMJ 2006;332:1412
- Ray Moynihan
- Byron Bay, Australia
The International Obesity Task Force has relied heavily on funding from the drug industry for a decade, despite being widely seen as an independent think tank and having ties to the World Health Organization.
Set up in the mid-1990s with help from grants from three drug companies, the task force aims to portray obesity as a “serious medical condition” and to promote better prevention and management strategies.
It has a high media profile and is highly influential. A senior US member and a well respected authority on obesity, William Dietz, is currently one of the driving forces behind a …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.